UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 80

Sortiert nach

Linezolid

Drugs (New York, N.Y.), 2000-04, Vol.59 (4), p.815-827

2000

Volltextzugriff (PDF)

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS

Neuropharmacology, 2000, Vol.39 (1), p.123-132

2000

Volltextzugriff (PDF)

Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis and acute pain

Drugs (New York, N.Y.), 2000-04, Vol.59 (4), p.957-980

2000

Volltextzugriff (PDF)

Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study

Annals of oncology, 2019-04, Vol.30, p.ii77-ii77

2019

Volltextzugriff (PDF)

Oxaliplatin : A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

Drugs (New York, N.Y.), 2000-10, Vol.60 (4), p.895-924

2000

Volltextzugriff (PDF)

Tolterodine : A review of its use in the treatment of overactive bladder

Drugs & aging, 2001, Vol.18 (4), p.277-304

2001

Volltextzugriff (PDF)

Raloxifene : A review of its use in postmenopausal osteoporosis

Drugs (New York, N.Y.), 2000-08, Vol.60 (2), p.379-411

2000

Volltextzugriff (PDF)

Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function

Journal of neurochemistry, 1998-09, Vol.71 (3), p.1271-1279

1998

Volltextzugriff (PDF)

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC

Annals of oncology, 2019-11, Vol.30, p.ix157-ix158

2019

Volltextzugriff (PDF)

Active detection of shielded special nuclear material - Dec 2012 AWE/NRL steel shielded campaign EJ301 liquid scintillation detector analysis

2013 IEEE Nuclear Science Symposium and Medical Imaging Conference (2013 NSS/MIC), 2013, p.1-6

2013

Volltextzugriff (PDF)

Prolonged-release mesalazine: A review of its therapeutic potential in ulcerative colitis and Crohn's disease

Drugs (New York, N.Y.), 2000-04, Vol.59 (4), p.929-956

2000

Volltextzugriff (PDF)

Pindolol‐insensitive [3H]‐5‐hydroxytryptamine binding in the rat hypothalamus; identity with 5‐hydroxytryptamine7 receptors

British journal of pharmacology, 1999-05, Vol.127 (1), p.236-242

1999

Volltextzugriff (PDF)

Active Interrogation of Depleted Uranium Using a Single Pulse, High-Intensity Photon and Mixed Photon-Neutron Source

IEEE transactions on nuclear science, 2015-04, Vol.62 (2), p.494-503

2015

Volltextzugriff (PDF)

Azimilide

Drugs (New York, N.Y.), 2000-02, Vol.59 (2), p.271-277

2000

Volltextzugriff (PDF)

Pulsed Power Active Interrogation of Shielded Fissionable Material

IEEE transactions on nuclear science, 2015-06, Vol.62 (3), p.1278-1287

2015

Volltextzugriff (PDF)

LBA4Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study

Annals of oncology, 2019-04, Vol.30 (Supplement_2)

2019

Volltextzugriff (PDF)

Mixed Source Interrogation of Steel Shielded Special Nuclear Material Using an Intense Pulsed Source

Physics procedia, 2015, Vol.66, p.206-215

2015

Volltextzugriff (PDF)

Exemestane: A review of its use in postmenopausal women with advanced breast cancer

Drugs (New York, N.Y.), 2000-06, Vol.59 (6), p.1279-1296

2000

Volltextzugriff (PDF)

Active Detection of Shielded Special Nuclear Material in the Presence of Variable High Backgrounds Using a Mixed Photon-Neutron Source

Physics procedia, 2015, Vol.66, p.216-225

2015

Volltextzugriff (PDF)

Azimilide. Commentary

Drugs (New York, N.Y.), 2000, Vol.59 (2), p.271-279

2000

Volltextzugriff (PDF)

Activation of sodium iodide detectors in an Active Interrogation environment

2012 IEEE Nuclear Science Symposium and Medical Imaging Conference Record (NSS/MIC), 2012, p.11-17

2012

Volltextzugriff (PDF)

Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine 7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function

Journal of neurochemistry, 1998-09, Vol.71 (3), p.1271-1279

1998

Volltextzugriff (PDF)

Immunohistochemical localisation of the 5-HT sub(2C) receptor protein in the rat CNS

Neuropharmacology, 1999-12, Vol.39 (1), p.123-132

1999

Volltextzugriff (PDF)

Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine sub(7) receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function

Journal of neurochemistry, 1998-09, Vol.71 (3), p.1271-1279

1998

Volltextzugriff (PDF)

Pindolol-insensitive [ super(3)H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine sub(7) receptors

British journal of pharmacology, 1999-05, Vol.127 (1), p.236-242

1999

Volltextzugriff (PDF)

1 – 25 von 80

Suche als RSS-Feed

Aktive Filter

ThemaExobiology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(75)
Tagungsberichte
(5)

Sprache

Englisch
(80)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

Science & Technology
(49)
Humans
(31)
Life Sciences & Biomedicine
(29)
Male
(16)
Physical Sciences
(16)
Female
(14)
Biological And Medical Sciences
(13)
Adult
(12)
Medical Sciences
(10)
Pharmacology & Pharmacy
(9)
Pharmacology. Drug Treatments
(9)
Animals
(8)
Middle Aged
(8)
Radiology, Nuclear Medicine & Medical Imaging
(8)
Aged
(7)
Endoscopy
(7)
Meteorites
(7)
Spectra
(7)
Toxicology
(7)
Extraterrestrial Geology
(6)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Linezolid

Immunohistochemical localisation of the 5-HT2C receptor protein in the rat CNS

Celecoxib: A review of its use in osteoarthritis, rheumatoid arthritis and acute pain

Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study

Oxaliplatin : A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies

Tolterodine : A review of its use in the treatment of overactive bladder

Raloxifene : A review of its use in postmenopausal osteoporosis

Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function

Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC

Active detection of shielded special nuclear material - Dec 2012 AWE/NRL steel shielded campaign EJ301 liquid scintillation detector analysis

Prolonged-release mesalazine: A review of its therapeutic potential in ulcerative colitis and Crohn's disease

Pindolol‐insensitive [3H]‐5‐hydroxytryptamine binding in the rat hypothalamus; identity with 5‐hydroxytryptamine7 receptors

Active Interrogation of Depleted Uranium Using a Single Pulse, High-Intensity Photon and Mixed Photon-Neutron Source

Azimilide

Pulsed Power Active Interrogation of Shielded Fissionable Material

LBA4Effect of post-study immunotherapy (IO) on overall survival (OS) outcome in patients with metastatic (m) NSCLC treated with first-line durvalumab (D) vs chemotherapy (CT) in the phase III MYSTIC study

Mixed Source Interrogation of Steel Shielded Special Nuclear Material Using an Intense Pulsed Source

Exemestane: A review of its use in postmenopausal women with advanced breast cancer

Active Detection of Shielded Special Nuclear Material in the Presence of Variable High Backgrounds Using a Mixed Photon-Neutron Source

Azimilide. Commentary

Activation of sodium iodide detectors in an Active Interrogation environment

Antisense Oligonucleotide‐Induced Reduction in 5‐Hydroxytryptamine 7 Receptors in the Rat Hypothalamus Without Alteration in Exploratory Behaviour or Neuroendocrine Function

Immunohistochemical localisation of the 5-HT sub(2C) receptor protein in the rat CNS

Antisense oligonucleotide-induced reduction in 5-hydroxytryptamine sub(7) receptors in the rat hypothalamus without alteration in exploratory behaviour or neuroendocrine function

Pindolol-insensitive [ super(3)H]-5-hydroxytryptamine binding in the rat hypothalamus; identity with 5-hydroxytryptamine sub(7) receptors

Aktive Filter

Suchergebnisse filtern